Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Isolated Langerhans Cell Histiocytosis Masquerading as Intradural Extramedullary Meningioma: Review on Histiocytic Disorders of Spine.

Journal of pediatric neurosciences·2019
Same author

Isolated Intraventricular Chronic Mucormycosis in an Immunocompetent Infant: A Rare Case with Review of the Literature.

World neurosurgery·2019
Same author

Practices and knowledge regarding dengue infection among the rural community of Haryana.

Journal of family medicine and primary care·2019
Same author

Atopy and Quality of Life in Pediatric Chronic Rhinosinusitis.

American journal of rhinology & allergy·2019
Same author

Ileosigmoid knotting: an unusual cause of acute intestinal obstruction with bowel gangrene.

BMJ case reports·2019
Same author

Surgical Outcome in an Iniencephaly Survivor: Case Report and Review of the Literature.

World neurosurgery·2019
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Desarrollo de Fármacos

Raj Kumar1, Rudra Pal1, Sukhvir Kaur1

  • 1Chitkara University School of Pharmacy, Chitkara University, Baddi, Himachal Pradesh, India.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Los ensayos clínicos que investigan la inflamación en la enfermedad de Alzheimer (EA) han aumentado desde 2015, con un cambio hacia técnicas avanzadas de imagen y moleculares para mejores dianas terapéuticas.

Palabras clave:
ensayos clínicosenfermedad de Alzheimerinflamaciónbiomarcadoresdesarrollo de fármacosterapias avanzadasneurocienciainmunología

Más Videos Relacionados

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Área de la Ciencia:

  • Neurociencia
  • Inmunología
  • Ensayos Clínicos

Sus antecedentes:

  • Investigaciones emergentes implican la inflamación en la patogénesis de la enfermedad de Alzheimer (EA).
  • La identificación de dianas terapéuticas para la EA en etapa temprana es crucial.

Objetivo del estudio:

  • Analizar las tendencias en los ensayos clínicos centrados en la inflamación en el desarrollo de fármacos para la EA.
  • Identificar posibles dianas terapéuticas para la intervención en la EA en etapa temprana.

Principales métodos:

  • Análisis de informes de ensayos clínicos sobre marcadores inflamatorios en la EA de ClinicalTrials.gov.
  • Se examinaron los estados de los estudios año por año (reclutando, completados, terminados, retirados).
  • Se resumieron las categorías de estudios, los resultados y los biomarcadores (por ejemplo, IL-6, TNF-α, citoquinas del LCR) con técnicas analíticas avanzadas.

Principales resultados:

  • Un aumento notable en los estudios de inflamación de la EA después de 2015, lo que indica un creciente interés en la investigación.
  • El 44% de los estudios se completaron y el 19% están reclutando, lo que demuestra una actividad de investigación sostenida.
  • Un cambio de biomarcadores tradicionales (IL-6, TNF-α) a técnicas avanzadas de imagen (exploraciones PET) y moleculares después de 2015.

Conclusiones:

  • La investigación confirma el creciente papel de la inflamación en la EA, con una tendencia hacia métodos avanzados de imagen y moleculares.
  • A pesar de los desafíos de reclutamiento, se han logrado avances significativos en la comprensión del papel de la inflamación en la EA.
  • La investigación futura debería integrar imágenes, marcadores moleculares e intervenciones clínicas para un manejo eficaz de la inflamación de la EA.